CIK 0001674416
- Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- Operating
- EIN
- 473173478
- Phone
- +1 617-315-4600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- 4 Open-market sale Director sold 35,473 shares at an average $18.63 ($660,888)
- 4 Open-market sale Chief Legal Officer sold 15,000 shares at an average $18.57 ($278,479)
- 4 Open-market sale Director sold 50,477 shares at an average $17.81 ($899,216)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 5,512 shares at an average $17.51 ($96,491)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 41,312 shares at an average $17.63 ($728,134)
- 4 Open-market sale Director sold 32,930 shares at an average $17.60 ($579,545)
- 4 Open-market sale Director sold 69,859 shares at an average $16.84 ($1,176,710)
- 4 Open-market sale Director sold 31,992 shares at an average $16.56 ($529,938)
- 4 Open-market sale Director sold 4,254 shares at $16.26 ($69,170)
- 4 Open-market sale Director sold 43,202 shares at an average $16.90 ($730,125)
- 4 Open-market sale Director sold 81,435 shares at an average $17.08 ($1,390,611)
- 4 Open-market sale Director sold 32,368 shares at an average $16.23 ($525,302)
- 4 Open-market sale Chief Executive Officer sold 10,825 shares at $15.37 ($166,388)
- 4 Open-market sale Chief Executive Officer sold 30,222 shares at an average $15.01 ($453,511)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Executive Officer sold 5,303 shares at an average $15.02 ($79,628)
Page 22 of 26 · 502 filings